Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Oct 23 2018

• By Mandy Jackson

Finance Watch

Related Content

AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)

Jul 17 2017

Deals Shaping the Medical Industry, December 2016

Dec 08 2016

Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go

Oct 16 2018

Paratek's Antibiotic Nuzyra Survived 20 Years – Now For The US Launch

Oct 03 2018

IPO Update: Returns Sag As Seven More Biopharmas Go Public In September

Oct 02 2018

Finance Watch: Bicycle Spins Toward Clinic With $52m Round; Stock Spikes Spur Offerings

Jun 02 2017

Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

Nov 29 2017

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Nov 21 2017

CARB-X Partnership Puts Antibiotics' Future In Biotech Startups' Hands

Jul 30 2016

BARDA backs Medicines/Rempex antibiotic with $90m award

Feb 06 2014

Medicines Company gains anti-infectives in $140m Rempex buy

Dec 05 2013

VC Roundup: Early-Stage Funding Slips Again In Third Quarter, Plus 15 New Financings

Oct 08 2016

Pipeline Watch: Phase III Top-Line Data With Givosiran, Soliris and Vascepa

Oct 01 2018

REPAIR Is Trying To Fix The Antibiotic Gap Left By Industry

Sep 12 2018

Novel-Mechanism Antibacterials And Microbiome-Friendly Agents Now Key For Summit Therapeutics

Sep 11 2018

Finance Watch: Rakuten Aspyrian Raises $150m VC Round For Laser-Activated Cancer Drugs

Aug 24 2018

Tetraphase's Broad Spectrum Antibiotic Xerava Priced To Move

Aug 28 2018

Venture Funding Deals: Celularity Launches With $250m; Generation Bio Grabs $100m Series B

Mar 06 2018

Alarm As Novartis Exits Antibiotics Space

Jul 12 2018

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

Jul 25 2018

Circle Of Life: Raptor Buys Quinsair After Its Return To Original Developer

Aug 22 2015

VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others

May 16 2016

US Approval Of Vabomere Could Help Alleviate TMC's Financial Troubles

Aug 31 2017

Raptor Buy Bolsters Horizon's Orphan Business As Primary Care Foots The Bill

Sep 13 2016

Related Companies

The Medicines Company

Horizon Therapeutics plc

Raptor Pharmaceutical Corp.

Horizon Therapeutics plc

Melinta Therapeutics, Inc.

Paratek Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

AstraZeneca PLC

Entasis Therapeutics Holdings Inc.

Summit Therapeutics plc

Nabriva Therapeutics plc.

Otsuka Holdings Co., Ltd.

Arcus Biosciences, Inc.

Harpoon Therapeutics

STORM Therapeutics Ltd

ORIC Pharmaceuticals, Inc.

Quentis Therapeutics Inc.

Turning Point Therapeutics Inc.

GSK plc

Castle Creek Biosciences, Inc.

Paragon Biosciences LLC

University of North Carolina at Chapel Hill

Stanford University

Additional Topics

Financing StartUps and SMEs Business Strategies Deals Commercial Infectious Diseases BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window